Enzyme-Responsive Drug Release In article number 2101926, Yi Liu, Pengfei Ge, Hao Zhang, and co-workers construct a Fe(III)-Shikonin metal-polyphenol-coordinated supramolecular nanomedicine for combined therapy of tumors. The as-prepared nanomedicine will disassemble into Fe2+ and Shikonin in response to the high concentration of glutathione in tumor cells, followed by the up-regulation of the intracellular reactive oxygen species level and the depletion of the intracellular glutathione level, resulting in the tumor cell death via ferroptosis and necroptosis.